These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 8748365)

  • 21. Kinetics and thermogenesis of medium-chain monocarboxylic and dicarboxylic acids in man: sebacate and medium-chain triglycerides.
    Mingrone G; Greco AV; Castagneto M; De Gaetano A; Tataranni PA; Raguso C
    JPEN J Parenter Enteral Nutr; 1993; 17(3):257-64. PubMed ID: 8505832
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of a multi-compartment pharmacokinetic model to characterize the exposure to Hexamoll® DINCH®.
    Schütze A; Lorber M; Gawrych K; Kolossa-Gehring M; Apel P; Brüning T; Koch HM
    Chemosphere; 2015 Jun; 128():216-24. PubMed ID: 25710321
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Absorption, distribution, metabolism and excretion of glucosamine sulfate. A review.
    Setnikar I; Rovati LC
    Arzneimittelforschung; 2001 Sep; 51(9):699-725. PubMed ID: 11642003
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiple-dose pharmacokinetics of ofloxacin, a new broad-spectrum antimicrobial agent.
    Dagrosa EE; Verho M; Malerczyk V; de Looze S; Hajdú P; Toyodera K
    Clin Ther; 1986; 8(6):632-45. PubMed ID: 3466701
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A new HPLC method for the direct analysis of triglycerides of dicarboxylic acids in biological samples.
    Capristo E; Mingrone G; De Gaetano A; Addolorato G; Greco AV; Gasbarrini G
    Clin Chim Acta; 1999 Nov; 289(1-2):11-21. PubMed ID: 10556649
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tissue distribution and plasma pharmacokinetics of UCN-01 at steady-state and following bolus administration in rats: influence of human alpha1-acid glycoprotein binding.
    Hedaya MA; Daoud SS
    Anticancer Res; 2001; 21(6A):4005-10. PubMed ID: 11911284
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma pharmacokinetics and tissue distribution of 17-(allylamino)-17-demethoxygeldanamycin (NSC 330507) in CD2F1 mice1.
    Egorin MJ; Zuhowski EG; Rosen DM; Sentz DL; Covey JM; Eiseman JL
    Cancer Chemother Pharmacol; 2001 Apr; 47(4):291-302. PubMed ID: 11345645
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Percutaneous absorption of azelaic acid in humans.
    Täuber U; Weiss C; Matthes H
    Exp Dermatol; 1992 Nov; 1(4):176-9. PubMed ID: 1365318
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Medium-chain triglycerides for parenteral nutrition: kinetic profile in humans.
    Mingrone G; De Gaetano A; Greco AV; Capristo E; Castagneto M; Gasbarrini G
    Nutrition; 1995; 11(5):418-22. PubMed ID: 8748191
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical pharmacology of mitoxantrone.
    Ehninger G; Proksch B; Heinzel G; Woodward DL
    Cancer Treat Rep; 1986 Dec; 70(12):1373-8. PubMed ID: 3791250
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A simple pharmacokinetic model of alendronate developed using plasma concentration and urine excretion data from healthy men.
    Chae JW; Seo JW; Mahat B; Yun HY; Baek IH; Lee BY; Kim DH; Kwon KI
    Drug Dev Ind Pharm; 2014 Oct; 40(10):1325-9. PubMed ID: 23886303
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma pharmacokinetics and tissue distribution in CD2F1 mice of Pc4 (NSC 676418), a silicone phthalocyanine photodynamic sensitizing agent.
    Egorin MJ; Zuhowski EG; Sentz DL; Dobson JM; Callery PS; Eiseman JL
    Cancer Chemother Pharmacol; 1999; 44(4):283-94. PubMed ID: 10447575
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Absorption, distribution, metabolism, and excretion of N,N-diethyl-M-toluamide in the rat.
    Schoenig GP; Hartnagel RE; Osimitz TG; Llanso S
    Drug Metab Dispos; 1996 Feb; 24(2):156-63. PubMed ID: 8742226
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Altered dose-to-effect of propofol due to pharmacokinetics in rats with experimental diabetes mellitus.
    Leal N; Calvo R; Agrad FZ; Lukas JC; de la Fuente L; Suarez E
    J Pharm Pharmacol; 2005 Mar; 57(3):317-25. PubMed ID: 15807987
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Absorption, distribution, metabolism and excretion of netilmicin in rats (III). Metabolic fate of 14C-netilmicin after intramuscular administration (author's transl)].
    Uda F; Fujino A; Tokiwa T
    Jpn J Antibiot; 1982 Apr; 35(4):967-78. PubMed ID: 7097991
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetic interpretation of erythromycin and tylosin activity in serum after intravenous administration of a single dose to cows.
    Baggot JD; Gingerich DA
    Res Vet Sci; 1976 Nov; 21(3):318-23. PubMed ID: 1030820
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of etofylline after intravenous and oral administration to humans.
    Zuidema J; Verhoeven J; Merkus FW
    Int J Clin Pharmacol Ther Toxicol; 1981 Jul; 19(7):310-3. PubMed ID: 7263108
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A human physiologically based pharmacokinetic model for trichloroethylene and its metabolites, trichloroacetic acid and free trichloroethanol.
    Fisher JW; Mahle D; Abbas R
    Toxicol Appl Pharmacol; 1998 Oct; 152(2):339-59. PubMed ID: 9853003
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolism of the plasticizer and phthalate substitute diisononyl-cyclohexane-1,2-dicarboxylate (DINCH(®)) in humans after single oral doses.
    Koch HM; Schütze A; Pälmke C; Angerer J; Brüning T
    Arch Toxicol; 2013 May; 87(5):799-806. PubMed ID: 23203454
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics of tiropramide after single doses in man.
    Arigoni R; Chisté R; Drovanti A; Makovec F; Senin P; Setnikar I
    Arzneimittelforschung; 1986 Apr; 36(4):738-44. PubMed ID: 3718598
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.